期刊文献+

胃癌患者CA125、CEA及G-17与临床病理特征的相关性分析

Correlation Analysis of CA125,CEA,G-17 and Clinicopathological Characteristics of Gastric Cancer Patients
下载PDF
导出
摘要 目的 探讨胃癌患者糖链抗原125(CA125)、癌胚抗原(CEA)、胃泌素-17(G-17)与临床病理特征的相关性。方法 选择2019年6月-2021年6月我院收治的112例胃癌患者作为研究对象,将所有患者的临床资料作为胃癌组,并选取同期体检健康者112例的临床资料作为健康组。比较胃癌组与健康组血清CA125、CEA及G-17水平,胃癌患者血清CA125、CEA及G-17与临床病理特征的相关性。结果 胃癌组血清CA125、CEA及G-17水平高于健康组,差异有统计学意义(P<0.05);在胃癌患者中病理Ⅲ、Ⅳ期、淋巴结转移、低分化的血清CA125、CEA及G-17阳性率高于阴性率(P<0.05),同时血清CA125阳性率分别与病理分期、淋巴结转移、分化程度成正相关(r=0.475,0.468,0.452,P<0.05);血清CEA阳性率分别与病理分期、淋巴结转移、分化程度成正相关(r=0.425,0.453,0.427,P<0.05);血清G-17阳性率分别与病理分期、淋巴结转移、分化程度成正相关(r=0.439,0.421,0.438,P<0.05)。结论 胃癌患者的血清CA125、CEA及G-17水平较高,且血清CA125、CEA及G-17阳性率与病理分期、淋巴结转移、分化程度均呈正相关,可为预后情况提供参考价值。 Objective To investigate correlation between clinical and pathological characteristics of carbohydrate antigen 125(CA125),carcinoembryonic antigen(CEA),and gastrin 17(G-17)of gastric cancer patients.Methods The paper chose 112 patients with gastric cancer admitted to our hospital from June 2019 to June 2021 as study objects,clinical data of patients were included in gastric cancer group,and clinical data of 112 healthy individuals with physical examination during the same period in health group.Levels of serum CA125,CEA,and G-17 between gastric cancer group and healthy group,correlation between serum CA125,CEA,and G-17 and clinical pathological characteristics of gastric cancer patients were compared.Results Levels of serum CA125,CEA,and G-17 in gastric cancer group were significantly higher than healthy group(P<0.05).Positive rates of serum CA125,CEA,and G-17 were higher than negative rates of gastric cancer patients,(P<0.05).Positive rate of serum CEA was positively correlated with pathological stage,lymph node metastasis,and degree of differentiation respectively(r=0.425,0.453,0.427,P<0.05).Positive rate of serum G-17 was positively correlated with pathological stage,lymph node metastasis,and degree of differentiation(r=0.439,0.421,0.438,P<0.05).Conclusion Levels of serum CA125,CEA,and G-17 of gastric cancer patients are relatively high,positive rates of serum CA125,CEA,and G-17 are positively correlated with pathological stage,lymph node metastasis,and differentiation,which can provide reference value for prognosis.
作者 何晓荣 田尧 HE Xiaorong;TIAN Yao(Gastroenterology Department,Hai'an People's Hospital,Nantong,Jiangsu 226600)
出处 《智慧健康》 2023年第4期115-118,共4页 Smart Healthcare
关键词 胃癌 糖链抗原125 癌胚抗原 胃泌素-17 临床病理特征 Gastric cancer Sugar chain antigen 125 Carcinoembryonic antigen Gastrin-17 Clinicopathological characteristics
  • 相关文献

二级参考文献58

  • 1Ajani JA,Bekaii-Saab T,Yang G. NCCN clinical practice guidelines in oncology:gastric cancer[M].2009.
  • 2Karam SM. Cellular origin of gastric cancer[J].Ann N Y Aced Sci,2008.162-168.
  • 3Hamashima C,Shibuya D,Yamazaki H. The Japaneseguidelines for gastric cancer screening[J].Jpn 1 Clin Oncol,2008,(04):259-267.
  • 4Leung WK,Wu MS,Kakugawa Y. Asia Pacific WorkingGroup on Gastric Cancer.Screening for gastric cancer in Asia:current evidence and practice[J].{H}LANCET ONCOLOGY,2008,(03):279-287.
  • 5Jatzko GR,Lisborg PH,Denk H. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan[J].{H}CANCER,1995,(08):1302-1312.
  • 6Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].{H}CA-A Cancer Journal for Clinicians,2005,(02):74-108.
  • 7Sierra A,Regueira FM,Hernlxndez-LiwGin JL. Role of the extended lymphadenectomy in gastric cancer surgery:experience in a single institution[J].{H}ANNALS OF SURGICAL ONCOLOGY,2003,(03):219-226.
  • 8董志伟;谷铣之.临床肿瘤学[M]{H}北京:人民卫生出版社,20029-27.
  • 9Enzinger PC,Benedetti JK,Meyerhardt JA. Impact of hospital volume on recurrence and survival after surgery for gastnc cancer[J].2007,(03):426-434.
  • 10MacDonald JS,Smalley SR,Benedetti J. Chemoradio-therapy after surgery compared with surgery alone for adeno-carcinoma of the stomach or gastroesophageal junction[J].{H}New England Journal of Medicine,2001,(10):725-730.

共引文献441

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部